![Novo Nordisk production facility](https://www.europeanpharmaceuticalreview.com/wp-content/uploads/Novo-Nordisk-Clayton-North-Carolina-US.-New-production-facilities-announced-24-June-2024.-To-be-completed-in-2027-2029-375x211.jpg)
The increased capacity will add 1.4 million ft2 of production space, double the combined square footage of all three of the company's existing facilities in
[the new facility will double] the combined square footage of all three of [Novo Nordisk]’s existing facilities in North Carolina”
Overall, the expansion will support
The facility is set to incorporate features that support environmental sustainability, such as roof-top solar panels and innovative water strategies, as well as advanced technology, according to
In 2016, the company announced a new facility, the single largest life sciences investment in
"
Novo Nordisk $11b acquisition to support manufacturing capacity
Further details about Novo Nordisk’s new production facility
The investment will also generate 1,000 new jobs. This is in addition to the company's current workforce in the region, which totals nearly 2,500 employees, the firm stated.
They added that in 2024, it anticipates increasing its actual production investments. In total, it plans to invest approximately
Initial construction work has begun on the new facility. Completion is expected between 2027 and 2029. Currently, worldwide, the pharmaceutical company has a five production sites in
Haemophilia drug could reduce treated bleeding episodes…
The post New US fill finish facility receives
© Russell Publishing Limited, 2024. All Rights Reserved., source